European Radiology

, Volume 27, Issue 6, pp 2474–2481 | Cite as

Haemodynamic changes in hepatocellular carcinoma and liver parenchyma under balloon occlusion of the hepatic artery

  • Fumie Sugihara
  • Satoru Murata
  • Tatsuo Ueda
  • Daisuke Yasui
  • Hidenori Yamaguchi
  • Izumi Miki
  • Chiaki Kawamoto
  • Eiji Uchida
  • Shin-ichiro Kumita
Interventional

Abstract

Objectives

To investigate haemodynamic changes in hepatocellular carcinoma (HCC) and liver under hepatic artery occlusion.

Methods

Thirty-eight HCC nodules in 25 patients were included. Computed tomography (CT) during hepatic arteriography (CTHA) with and without balloon occlusion of the hepatic artery was performed. CT attenuation and enhancement volume of HCC and liver with and without balloon occlusion were measured on CTHA. Influence of balloon position (segmental or subsegmental branch) was evaluated based on differences in HCC-to-liver attenuation ratio (H/L ratio) and enhancement volume of HCC and liver.

Results

In the segmental group (n = 20), H/L ratio and enhancement volume of HCC and liver were significantly lower with balloon occlusion than without balloon occlusion. However, in the subsegmental group (n = 18), H/L ratio was significantly higher and liver enhancement volume was significantly lower with balloon occlusion; HCC enhancement volume was similar with and without balloon occlusion. Rate of change in H/L ratio and enhancement volume of HCC and liver were lower in the segmental group than in the subsegmental group. There were significantly more perfusion defects in HCC in the segmental group.

Conclusions

Hepatic artery occlusion causes haemodynamic changes in HCC and liver, especially with segmental occlusion.

Key Points

Hepatic artery occlusion causes haemodynamic changes in hepatocellular carcinoma and liver.

Segmental occlusion decreased rate of change in hepatocellular carcinoma-to-liver attenuation ratio.

Subsegmental occlusion increased rate of change in hepatocellular carcinoma-to-liver attenuation ratio.

Hepatic artery occlusion decreased enhancement volume of hepatocellular carcinoma and liver.

Hepatic artery occlusion causes perfusion defects in hepatocellular carcinoma.

Keywords

Balloon occlusion Therapeutic chemoembolization Hepatocellular carcinoma Haemodynamics Multidetector computed tomography 

Abbreviations

B-TACE

Balloon-occluded transarterial chemoembolization

CT

Computed tomography

CTHA

Computed tomography hepatic arteriography

HCC

Hepatocellular carcinoma

H/L

Hepatocellular carcinoma to liver parenchyma attenuation ratio

HU

Hounsfield units

TACE

Transarterial chemoembolization

Notes

Acknowledgments

The scientific guarantor of this publication is Satoru Murata. The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article. The authors state that this work has not received any funding. No complex statistical methods were necessary for this paper. Institutional Review Board approval was obtained. Written informed consent was obtained from all patients in this study. None of the study subjects or cohorts have been previously reported. Methodology: prospective, observational, performed at one institution.

References

  1. 1.
    Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61:69–90CrossRefPubMedGoogle Scholar
  2. 2.
    Llovet JM, Brú C, Bruix J (1999) Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 19:329–338CrossRefPubMedGoogle Scholar
  3. 3.
    Forner A, Llovet JM, Bruix J (2012) Hepatocellular carcinoma. Lancet 379:1245–1255CrossRefPubMedGoogle Scholar
  4. 4.
    European Association for the Study of the Liver, European Organisation for Research and Treatment of Cancer (2012) EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 56:908–943CrossRefGoogle Scholar
  5. 5.
    Bruix J, Sherman M, Practice Guidelines Committee, American Association for the Study of Liver Diseases (2005) Management of hepatocellular carcinoma. Hepatology 42:1208–1236CrossRefPubMedGoogle Scholar
  6. 6.
    Cammà C, Schepis F, Orlando A et al (2002) Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials. Radiology 224:47–54CrossRefPubMedGoogle Scholar
  7. 7.
    Lo CM, Ngan H, Tso WK et al (2002) Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 35:1164–1171CrossRefPubMedGoogle Scholar
  8. 8.
    Llovet JM, Bruix J (2003) Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology 37:429–442CrossRefPubMedGoogle Scholar
  9. 9.
    Yamada R, Yamaguchi S, Nakatsuka H et al (1981) Balloon-occluded arterial infusion--a new method for administration of anticancer drugs [in Japanese]. Nihon Igaku Hoshasen Gakkai Zasshi 41:894–896PubMedGoogle Scholar
  10. 10.
    Ishizaka H, Ishijima H, Katsuya T, Horikoshi H, Koyama Y (1997) Compulsory superselective arterial embolization in hypovascular local hepatic tumor ablation. Microballoon coaxial catheterization. Acta Radiol 38:836–839PubMedGoogle Scholar
  11. 11.
    Irie T, Kuramochi M, Takahashi N (2013) Dense accumulation of lipiodol emulsion in hepatocellular carcinoma nodule during selective balloon-occluded transarterial chemoembolization: measurement of balloon-occluded arterial stump pressure. Cardiovasc Intervent Radiol 36:706–713CrossRefPubMedGoogle Scholar
  12. 12.
    Ishikawa T, Abe S, Inoue R et al (2014) Predictive factor of local recurrence after balloon-occluded TACE with miriplatin (MPT) in hepatocellular carcinoma. PLoS One 9, e103009CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Arai H, Abe T, Takayama H et al (2015) Safety and efficacy of balloon-occluded transcatheter arterial chemoembolization using miriplatin for hepatocellular carcinoma. Hepatol Res 45:663–666CrossRefPubMedGoogle Scholar
  14. 14.
    Murata S, Mine T, Sugihara F et al (2014) Interventional treatment for unresectable hepatocellular carcinoma. World J Gastroenterol 20:13453–13465CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Michels NA (1966) Newer anatomy of the liver and its variant blood supply and collateral circulation. Am J Surg 112:337–347CrossRefPubMedGoogle Scholar
  16. 16.
    Takeuchi Y, Arai Y, Inaba Y, Ohno K, Maeda T, Itai Y (1998) Extrahepatic arterial supply to the liver: observation with a unified CT and angiography system during temporary balloon occlusion of the proper hepatic artery. Radiology 209:121–128CrossRefPubMedGoogle Scholar
  17. 17.
    Tohma T, Cho A, Okazumi S et al (2005) Communicating arcade between the right and left hepatic arteries: evaluation with CT and angiography during temporary balloon occlusion of the right or left hepatic artery. Radiology 237:361–365CrossRefPubMedGoogle Scholar
  18. 18.
    Murata S, Tajima H, Abe Y et al (2005) Transcatheter management for multiple liver tumors after hepatic artery obstruction following reservoir placement. Hepatogastroenterology 52:852–856PubMedGoogle Scholar
  19. 19.
    Koehler RE, Korobkin M, Lewis F (1975) Arteriographic demonstration of collateral arterial supply to the liver after hepatic artery ligation. Radiology 117:49–54CrossRefPubMedGoogle Scholar
  20. 20.
    Itai Y, Moss AA, Goldberg HI (1982) Transient attenuation difference of lobar or segmental distribution detected by dynamic computed tomography. Radiology 144:835–839CrossRefPubMedGoogle Scholar
  21. 21.
    Itai Y, Murata S, Kurosaki Y (1995) Straight border sign of the liver: spectrum of CT appearances and causes. Radiographics 15:1089–1102CrossRefPubMedGoogle Scholar
  22. 22.
    Lautt WW, Legare DJ, Ezzat WR (1990) Quantitation of the hepatic arterial buffer response to graded changes in portal blood flow. Gastroenterology 98:1024–1028CrossRefPubMedGoogle Scholar
  23. 23.
    Jakab F, Ráth Z, Schmal F, Nagy P, Faller J (1995) The interaction between hepatic arterial and portal venous blood flows; simultaneous measurement by transit time ultrasonic volume flowmetry. Hepatogastroenterology 42:18–21PubMedGoogle Scholar

Copyright information

© European Society of Radiology 2016

Authors and Affiliations

  • Fumie Sugihara
    • 1
  • Satoru Murata
    • 1
  • Tatsuo Ueda
    • 1
  • Daisuke Yasui
    • 1
  • Hidenori Yamaguchi
    • 1
  • Izumi Miki
    • 1
  • Chiaki Kawamoto
    • 2
  • Eiji Uchida
    • 3
  • Shin-ichiro Kumita
    • 1
  1. 1.Department of Radiology, Center for Advanced Medical TechnologyNippon Medical SchoolTokyoJapan
  2. 2.Department of Internal MedicineNippon Medical SchoolTokyoJapan
  3. 3.Department of SurgeryNippon Medical SchoolTokyoJapan

Personalised recommendations